TG Therapeutics | TGTX - Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.22B 329M 2026-03
Alaunos Therapeutics USD 0 18K 2024-09
Amgen USD 1.6B 187M 2026-03
Ardelyx USD 4.81M 6.04M 2026-03
Bayer EUR 5.23B 731M 2026-03
Biogen USD 797.5M 302M 2026-03
Corcept Therapeutics USD 2.88M 338K 2026-03
Curis USD 314K 9.96M 2025-12
Gilead Sciences USD 1.44B 174M 2026-03
J&J USD 8.07B 103M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Novartis USD 3.46B 83M 2026-03
Novavax USD 22.1M 608K 2025-12
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
TG Therapeutics USD 33.51M 4.63M 2026-03
Verastem USD 2.89M 2.88M 2025-12
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03